Balyasny Asset Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
+970,862
| New | +$1.13M | ﹤0.01% | 1352 |
|
|
2025
Q1 | – | Sell |
-57,592
| Closed | -$175K | – | 2475 |
|
|
2024
Q4 | $175K | Sell |
57,592
-11,070
| -16% | -$33.5K | ﹤0.01% | 1759 |
|
|
2024
Q3 | $253K | Buy |
68,662
+28,451
| +71% | +$105K | ﹤0.01% | 1738 |
|
|
2024
Q2 | $164K | Sell |
40,211
-19,054
| -32% | -$77.9K | ﹤0.01% | 1729 |
|
|
2024
Q1 | $934K | Buy |
59,265
+47,912
| +422% | +$755K | ﹤0.01% | 1283 |
|
|
2023
Q4 | $172K | Buy |
+11,353
| New | +$172K | ﹤0.01% | 1766 |
|
|
2023
Q2 | – | Sell |
-35,182
| Closed | -$605K | – | 2377 |
|
|
2023
Q1 | $605K | Buy |
+35,182
| New | +$605K | ﹤0.01% | 1486 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2811 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2800 |
|